FDA Approves Merck’s Lipfendra, the First Oral PCSK9 Inhibitor, Reigniting Debate on Accelerated Review Programs
admin The U.S. Food and Drug Administration (FDA) has granted approval to Lipfendra, a groundbreaking new...
stocks
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss
Boston, MA – Veradermics, a burgeoning biopharmaceutical firm, has announced groundbreaking results from its Phase...
Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics
Pharmaceutical giant Eli Lilly has announced its intention to acquire AtaiBeckley, a leading specialist in...
Celcuity Secures Landmark FDA Approval for Breast Cancer Drug Revtorpyk Amidst Investor Concerns Over Launch Delay and Prescribing Information
Celcuity, a burgeoning player in the biopharmaceutical sector, marked a pivotal milestone on Tuesday, July...
UK Pharma Giants Deepen Strategic Alliances with Chinese Counterparts Amidst Intensifying Geopolitical Scrutiny
London, UK – July 8, 2026 – In a series of significant strategic moves that...
Bionyra, a biotechnology company building new biologics to treat immune diseases, emerged from stealth Monday with $165 million.
The biotech landscape witnessed a significant entry this week as Bionyra, a meticulously incubated biotechnology...
Pfizer CFO to step down; Denali sells a regulatory fast-pass
The dynamic biopharmaceutical sector witnessed a series of significant developments this week, reflecting ongoing shifts...
Legend Biotech’s In Vivo CAR-T Therapy LB2501 Achieves Full Remissions in Initial Lymphoma Trial, Signaling a Potential Paradigm Shift in Cell Therapy
Shanghai, China – June 3, 2026 – Legend Biotech, a prominent biopharmaceutical company, has announced...
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
The pharmaceutical landscape witnessed a dynamic week marked by significant market fluctuations, pivotal regulatory advancements,...
European Regulators Endorse Sanofi’s Tolebrutinib for Multiple Sclerosis, Diverging from FDA Stance
Sanofi’s experimental multiple sclerosis treatment, tolebrutinib, has received a crucial positive recommendation from European drug...
